Candel Therapeutics (CADL) Witnessed Dramatic Rise On Trial Update
Candel Therapeutics, Inc. (NASDAQ: CADL) stock experienced a remarkable surge in its value during the preceding trading session, escalating by a notable 280.95% to reach a concluding figure of $6.40. This substantial upswing in CADL stock ensued subsequent to the dissemination of encouraging interim findings from a clinical trial. Candel Therapeutics (CADL) disclosed updated interim […]